<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0185-3325</journal-id>
<journal-title><![CDATA[Salud mental]]></journal-title>
<abbrev-journal-title><![CDATA[Salud Ment]]></abbrev-journal-title>
<issn>0185-3325</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0185-33252005000100010</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Treatment preference and attitude toward pharmacotherapy and psychotherapy in Latin America. ULAD Task Force]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Heinze]]></surname>
<given-names><![CDATA[Gerhard]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cortés]]></surname>
<given-names><![CDATA[José F.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Nacional de Psiquiatría Ramón de la Fuente  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2005</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2005</year>
</pub-date>
<volume>28</volume>
<numero>1</numero>
<fpage>10</fpage>
<lpage>17</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0185-33252005000100010&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0185-33252005000100010&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0185-33252005000100010&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: The development of psychopharmacolgy has reached a considerable progress in the treatment of mental illnesses, although patients have an ambivalent opinion regarding its use. It is generally believed that psychoactive drugs produce secondary effects, such as the potential capacity to create addiction. Little is known about the health professionals' attitude towards the risks or benefits of psychopharmacology in the treatment of mental illnesses.  Objective To determine the preferences towards the type of treatment (psychopharmacology vs. psychotherapy) and the attitudes in regard to the specific use of psychodrugs that prevail among health professionals in 13 countries of Latin America.  Method A total of l868 surveys was applied to psychiatrists, non-psychiatric doctors, and psychologists in l3 countries of Latin America. The survey covered the following items: a) questionnaire on the preferences regarding the treatment of mental illnesses, including personality disorders; b) attitude scale on the use of psychodrugs, and c) patient's attitude perceived by doctors while prescribing psychotherapeutical drugs.  Results Pharmacotherapy was preferred by non-psychiatric doctors; psychologists had a negative attitude towards its use pointing out its secondary effects and the risk of addiction; psychiatrists and non-psychiatric doctors held a more favorable opinion. Doctors' opinion as to the patients' attitude towards psychotherapeutical drugs indicates that the latter accept taking them when they are properly informed regarding its use.  Conclusión There is no doubt that psychiatrists and non-psychiatric doctors have a better knowledge about the benefits offered by psychoactive drugs and their potential secondary effects. Psychologists postulate psychotherapy as basic treatment because their knowledge about the benefits of pharmacological treatment is limited. Nonpsychiatric doctors have a medical education that permits them to know more deeply the therapeutical action of psychotherapeutical drugs despite knowing less about the psychotherapeutical process.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: Aunque el desarrollo de la psicofarmacología ha presentado considerables avances en el tratamiento de las enfermedades mentales, los pacientes tienen una opinión ambivalente acerca de su uso. En general, se piensa que los fármacos psicoactivos presentan efectos secundarios como su potencial capacidad para generar adicción. Se conoce poco acerca de la actitud que tienen los profesionales de la salud sobre el riesgo-beneficio del uso de la psicofarmacología en el tratamiento de las enfermedades mentales.  Objetivo Determinar las preferencias hacia el tratamiento (psicofarmacología vs. psicoterapia) y la actitud hacia el uso específico de los psicofármacos en profesionistas de la salud de 13 países latinoamericanos.  Método Se aplicaron 1868 encuestas a psiquiatras, médicos no psiquiatras y psicólogos de 13 países latinoamericanos. La encuesta desarrollada contó con los siguientes apartados: a) Cuestionario sobre las preferencias de tratamiento en 11 enfermedades mentales, incluidos trastornos de la personalidad; b) escala de actitud sobre el uso de psicofármacos, c) actitud del paciente percibida por los médicos cuando prescriben psicofármacos.  Resultados En la preferencia por el tratamiento, entre los médicos no psiquiatras predominó la farmacoterapia. Los psicólogos manifiestan una actitud negativa, indicando sus efectos secundarios y el riesgo de adicción. Los médicos psiquiatras y no psiquiatras opinaron más favorablemente. La actitud del paciente hacia los psicofármacos, en opinión de los médicos, indica que aceptan su uso cuando son informados adecuadamente.  Conclusiones Es indudable que los médicos psiquiatras y no psiquiatras tienen un mayor conocimiento sobre los beneficios que proporcionaron los fármacos psicoactivos; también poseen un mejor conocimiento de los efectos secundarios potenciales. Los psicólogos postulan como tratamiento primordial la psicoterapia por su limitado conocimiento de los beneficios del tratamiento psicofármacológico. Los psiquiatras tienen una formación médica que les permite conocer con mayor profundidad las acciones terapéuticas de los psicofármacos y tienen menos conocimiento del proceso psicoterapéutico.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Psychodrugs]]></kwd>
<kwd lng="en"><![CDATA[attitude]]></kwd>
<kwd lng="en"><![CDATA[pharmacotherapy]]></kwd>
<kwd lng="en"><![CDATA[psychotherapy]]></kwd>
<kwd lng="es"><![CDATA[Psicofármacos]]></kwd>
<kwd lng="es"><![CDATA[actitud]]></kwd>
<kwd lng="es"><![CDATA[farmacoterapia]]></kwd>
<kwd lng="es"><![CDATA[psicoterapia]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Angermeyer]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Helt]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pro and contra: psychoterapy and psychopharmacotherapy attitude of the public]]></article-title>
<source><![CDATA[Psychother Psychosom Med Psychol]]></source>
<year>1993</year>
<volume>43</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>286-92</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Angermeyer]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Matschinger]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Attitude of medical students to treatment with psychotropic drugs. 1: Comparison between medical students and the general population]]></article-title>
<source><![CDATA[Psychiatry Prax]]></source>
<year>1994</year>
<volume>21</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>58-63</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benkert]]></surname>
<given-names><![CDATA[OHM]]></given-names>
</name>
<name>
<surname><![CDATA[Kepplinger]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Sobota Psychopharmaka im Widerstreit]]></source>
<year>1995</year>
<publisher-loc><![CDATA[Berlin ]]></publisher-loc>
<publisher-name><![CDATA[Heidelber]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benkert]]></surname>
<given-names><![CDATA[OHM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection]]></article-title>
<source><![CDATA[J Nervous Mental]]></source>
<year>1997</year>
<volume>185</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>151-8</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heinze]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cortes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Attitudes of health professionals towards prescribing psychodrugs]]></article-title>
<source><![CDATA[Salud Mental]]></source>
<year>1999</year>
<volume>22</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hillert]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sandmann]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Attitude of medical students to treatment with psychotropic drugs. 2: Change in attitude in the course of medical education]]></article-title>
<source><![CDATA[Psychiatry Prax]]></source>
<year>1994</year>
<volume>21</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>64-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hillert]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sandmann]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Psychopharmaceutical drugs in the mass media. Results of a systematic analysis of text contents and images]]></article-title>
<source><![CDATA[Nervenarzt]]></source>
<year>1995</year>
<volume>66</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>835-44</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hillert]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sandmann]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Psychopharmacological drugs as represented in the press: results of systematic analysis of newpapers and popular magazines]]></article-title>
<source><![CDATA[Pharmacopsychiat]]></source>
<year>1996</year>
<volume>29</volume>
<page-range>67-71</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manheimer]]></surname>
<given-names><![CDATA[DI ST]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Popular attitudes and beliefs about tranquilizers]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Davison]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Balter]]></surname>
<given-names><![CDATA[GD]]></given-names>
</name>
</person-group>
<source><![CDATA[Amer J Psychiatry]]></source>
<year>1973</year>
<volume>130</volume>
<page-range>1248-53</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nunnally]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<source><![CDATA[Popular conceptions of mental health]]></source>
<year>1961</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schneider]]></surname>
<given-names><![CDATA[US]]></given-names>
</name>
<name>
<surname><![CDATA[Wieser]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Der psychich kranke in den massenmedien. Ergebnisse einer systematischen inhaltsanalyse. Fortscher]]></article-title>
<source><![CDATA[Neurol Psychiat]]></source>
<year>1972</year>
<volume>40</volume>
<page-range>136-63</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Putten]]></surname>
<given-names><![CDATA[TPRA]]></given-names>
</name>
<name>
<surname><![CDATA[May]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Response to antipsychotic medication: The doctor and the consumer's view]]></article-title>
<source><![CDATA[Amer J Psychiatry]]></source>
<year>1984</year>
<volume>141</volume>
<page-range>6-19</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heinze]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cortes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Attitudes of health professionals towards prescribing drugs]]></article-title>
<source><![CDATA[Salud Mental]]></source>
<year>1999</year>
<volume>22</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Keller]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A comparison, the cognitive behavioral-analysis system of psychotherapy and their combination for the treatment of clinical depression]]></article-title>
<source><![CDATA[New England J Medicine]]></source>
<year>2000</year>
<volume>342</volume>
<numero>20</numero>
<issue>20</issue>
<page-range>1462-70</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hollon]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Tase]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Markowitz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment and prevention of depression]]></article-title>
<source><![CDATA[Psychological Science Public Interest]]></source>
<year>2002</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>39-77</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
